{"count":61,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+1414&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/9fb65ecc-d100-4763-bfdc-17860017431d/","filing_uuid":"9fb65ecc-d100-4763-bfdc-17860017431d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/9fb65ecc-d100-4763-bfdc-17860017431d/print/","filing_document_content_type":"text/html","income":null,"expenses":"50973.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Steve Issenman","dt_posted":"2026-04-10T12:57:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"10 W. Lafayette Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Trenton","registrant_state":"NJ","registrant_zip":"08608","registrant":{"id":75251,"url":"https://lda.gov/api/v1/registrants/75251/","house_registrant_id":36035,"name":"HEALTHCARE INSTITUTE OF NEW JERSEY","description":"government affairs for biopharmaceutical and medical device trade association","address_1":"10 W. Lafayette Street","address_2":null,"address_3":null,"address_4":null,"city":"Trenton","state":"NJ","state_display":"New Jersey","zip":"08608","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVE ISSENMAN","contact_telephone":"+1 732-729-9619","dt_updated":"2026-07-15T15:26:57.674024-04:00"},"client":{"id":167699,"url":"https://lda.gov/api/v1/clients/167699/","client_id":12,"name":"HEALTHCARE INSTITUTE OF NEW JERSEY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-12-08"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Generally promoting awareness of the biopharmaceutical and medical technology sectors. Generally opposing the imposition of price controls in the Medicare Part D program or elsewhere. Generally supporting intellectual property rights. Generally opposing various legislative and executive efforts to impose an international price index. Generally promoting awareness of increasing antimicrobial/antifungal resistance. Supporting the extension of the SBIR program. Generally supporting changes to the 340B program. Generally supporting efforts to require pharmacy benefit managers (PBMs) to pass on rebates to patients. Raising awareness within Congressional offices about Ethylene Oxide and EPA proposed regulations. Opposing proposed FTC changes to non-compete clauses. Supporting the restoration of the orphan drug tax credit (Cameron's Law, H.R. 1414). Supporting the modernization of prescribing information to allow digital in lieu of printed information, H.R. 4132 and S. 2027. Supporting Ensuring Patient Access to Critical Breakthrough Products Act/MCET (H.R. 1691 in the previous Congress). Supporting the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369 in the previous Congress). Supporting the Saving Access to Laboratory Services (SALSA) Act (H.R. 2377 in the previous Congress). Supporting the Protecting Patients Against PBM Abuses Act (H.R. 2880 in the previous Congress). Supporting the PASTEUR Act (H.R. 2940 and S. 1355 in the previous Congress). Supporting the Treat And Reduce Obesity Act (H.R. 4818, S. 2407 in the previous Congress). Supporting the Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 5391 and S. 2764 in the previous Congress). Supporting the Rare Pediatric Disease Priority Review Voucher Act (H.R. 1262 and S. 932). Supporting the Maintaining Investments in New Innovation (MINI) Act (H.R. 1672). Supporting the Delinking Revenue from Unfair Gouging (DRUG) Act (H.R. 6283 in the previous Congress). Supporting changes to the small molecule portions of the Inflation Reduction Act (H.R. 1492 and S. 832). Supporting \"cap and smooth\" efforts within the Inflation Reduction Act's cap on out-of-pocket expenses. Opposing pricing policies related to \"Most Favored Nation\" proposals and indexing to international prices. Opposing tariffs on pharmaceutical and medical device products. Opposing CMSs proposed interpretation of a Qualifying Single Source Drug (QSSD). Generally providing thoughts on federal data privacy transparency and security policies. Submitting comments opposing proposed changes to bona fide fee structures. Generally opposing CMMI's demonstration project on prior authorization in the Medicare program. Supporting the RESULTS Act, HR 5269 and S.2761. Opposing CMS GUARD and GLOBE pricing model proposals. Opposing HR 3375 and S 1587, \"Most Favored Nation\" legislation. Supporting the PBM FAIR Act, H.R. 68937 and S. 3549.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45619,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"ISSENMAN","suffix":null,"suffix_display":null},"covered_position":"Cong. Page (87-88), Congressional Aide (1990's)","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/07831196-5b8a-4169-8087-26040d7fa487/","filing_uuid":"07831196-5b8a-4169-8087-26040d7fa487","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/07831196-5b8a-4169-8087-26040d7fa487/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Richard M. Gold, Partner","dt_posted":"2026-04-10T14:26:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 17th Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":18466,"url":"https://lda.gov/api/v1/registrants/18466/","house_registrant_id":30825,"name":"HOLLAND & KNIGHT LLP","description":"Law Firm","address_1":"800 17th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RICHARD GOLD","contact_telephone":"+1 202-955-3000","dt_updated":"2026-07-30T20:48:41.410941-04:00"},"client":{"id":209574,"url":"https://lda.gov/api/v1/clients/209574/","client_id":1010457,"name":"BLACK WOMEN'S HEALTH IMPERATIVE","general_description":"Nonprofit organization","client_government_entity":false,"client_self_select":null,"state":"GA","state_display":"Georgia","country":"US","country_display":"United States of America","ppb_state":"GA","ppb_state_display":"Georgia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Women's health care issues; outreach related to Sickle Cell and other rare disease legislation; H.R. 1750 - Health Equity and Rare Disease Act of 2025; H.R. 1414 - Camerons Law; S.822 - Scientific EXPERT Act of 2025; H.R.1262 - Mikaela Naylon Give Kids a Chance Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139205,"prefix":"mr","prefix_display":"MR.","first_name":"MICAH","nickname":null,"middle_name":null,"last_name":"BURBANKS-IVEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148957,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"BROSSI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":40247,"prefix":null,"prefix_display":null,"first_name":"SHAWNA","nickname":null,"middle_name":null,"last_name":"FRANCIS WATLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/bc6ae490-c2bb-4d0e-a2f2-40154e690f9f/","filing_uuid":"bc6ae490-c2bb-4d0e-a2f2-40154e690f9f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/bc6ae490-c2bb-4d0e-a2f2-40154e690f9f/print/","filing_document_content_type":"text/html","income":null,"expenses":"180000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cate McCanless","dt_posted":"2026-04-14T10:30:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"630 W Germantown Pike","registrant_address_2":"Suite 215","registrant_different_address":false,"registrant_city":"Plymouth Meeting","registrant_state":"PA","registrant_zip":"19462","registrant":{"id":401105020,"url":"https://lda.gov/api/v1/registrants/401105020/","house_registrant_id":null,"name":"HARMONY BIOSCIENCES","description":"pharmaceuticals","address_1":"630 W Germantown pike","address_2":"Suite 215","address_3":null,"address_4":null,"city":"plymouth meeting","state":"PA","state_display":"Pennsylvania","zip":"19462","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CATE MCCANLESS","contact_telephone":"+1 202-420-7888","dt_updated":"2026-07-30T13:20:38.186535-04:00"},"client":{"id":203037,"url":"https://lda.gov/api/v1/clients/203037/","client_id":12,"name":"HARMONY BIOSCIENCES","general_description":"pharmaceuticals","client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-03"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Cameron's Law (HR 1414) EPIC Act (HR 1492/S 832) HR 1672 Maintaining Investments in New Innovation Act Issues related to protecting patient access to medicines Issues related to protecting orphan drug policies Issues related to most-favored-nation policies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146555,"prefix":"ms","prefix_display":"MS.","first_name":"SUSANNA","nickname":null,"middle_name":"AGUIRRE","last_name":"HASTINGS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69985,"prefix":null,"prefix_display":null,"first_name":"CATE","nickname":null,"middle_name":null,"last_name":"MCCANLESS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/02b178e2-9dcb-46fa-a2a7-41bc8ff2a9ec/","filing_uuid":"02b178e2-9dcb-46fa-a2a7-41bc8ff2a9ec","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/02b178e2-9dcb-46fa-a2a7-41bc8ff2a9ec/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig Monson","dt_posted":"2026-04-17T14:07:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":175642,"url":"https://lda.gov/api/v1/clients/175642/","client_id":1006245,"name":"THE CAMPAIGN FOR SUSTAINABLE RX PRICING","general_description":"A coalition of organizations working on market-based solutions to drug pricing.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-07-12"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act S. 1032/H.R. 1843 - Increasing Transparency in Generic Drug Applications Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/s. 1533 - the Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e450d393-856f-4251-a32f-bf940cec1076/","filing_uuid":"e450d393-856f-4251-a32f-bf940cec1076","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e450d393-856f-4251-a32f-bf940cec1076/print/","filing_document_content_type":"text/html","income":null,"expenses":"1140000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Samantha Ventimiglia","dt_posted":"2026-04-17T15:04:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"50 Northern Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02210","registrant":{"id":40027242,"url":"https://lda.gov/api/v1/registrants/40027242/","house_registrant_id":39888,"name":"VERTEX PHARMACEUTICALS INCORPORATED","description":"Global biotechnology company","address_1":"50 Northern Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02210","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SAMANTHA VENTIMIGLIA","contact_telephone":"+1 202-264-3511","dt_updated":"2026-07-29T12:53:27.346758-04:00"},"client":{"id":188223,"url":"https://lda.gov/api/v1/clients/188223/","client_id":48,"name":"VERTEX PHARMACEUTICALS INCORPORATED","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":"Leg. Director, Rep. Suzan DelBene (1/19-7/22); Sr. Leg. Asst., Rep. Suzan DelBene (10/17-1/19); Health Policy Advisor, Rep. Steve Israel (2/16-12/16); Leg. Asst., Rep. Steve Israel (5/13-12/14); Staff Asst., Rep. Steve Israel (12/12-05/13)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":"Leg. Director, Rep. Suzan DelBene (1/19-7/22); Sr. Leg. Asst., Rep. Suzan DelBene (10/17-1/19); Health Policy Advisor, Rep. Steve Israel (2/16-12/16); Leg. Asst., Rep. Steve Israel (5/13-12/14); Staff Asst., Rep. Steve Israel (12/12-05/13)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":10,"name":"Vice President of the U.S."},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Corporate tax reform; H.R. 1414 - Cameron's Law, Preservation of Orphan Drug Tax Credit.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Education about non-opioid pain therapies and patient access to non-opioid medicines, updates on coverage progress at the VHA and CMS.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":"Leg. Director, Rep. Suzan DelBene (1/19-7/22); Sr. Leg. Asst., Rep. Suzan DelBene (10/17-1/19); Health Policy Advisor, Rep. Steve Israel (2/16-12/16); Leg. Asst., Rep. Steve Israel (5/13-12/14); Staff Asst., Rep. Steve Israel (12/12-05/13)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Intellectual property reforms to address unfair trade practices in Argentina and Russia.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":"Leg. Director, Rep. Suzan DelBene (1/19-7/22); Sr. Leg. Asst., Rep. Suzan DelBene (10/17-1/19); Health Policy Advisor, Rep. Steve Israel (2/16-12/16); Leg. Asst., Rep. Steve Israel (5/13-12/14); Staff Asst., Rep. Steve Israel (12/12-05/13)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to the Defense Health Agency and service member access to non-opioid alternatives, including reinstating the DHA Benefits Advisory Panel and the structured formulary management process.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c3f1dd78-8f2c-4a14-b826-150a8b5cac40/","filing_uuid":"c3f1dd78-8f2c-4a14-b826-150a8b5cac40","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/c3f1dd78-8f2c-4a14-b826-150a8b5cac40/print/","filing_document_content_type":"text/html","income":null,"expenses":"200000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christopher Porter","dt_posted":"2026-04-20T12:55:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3611 Valley Centre Drive","registrant_address_2":"Suite 300","registrant_different_address":true,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401104190,"url":"https://lda.gov/api/v1/registrants/401104190/","house_registrant_id":null,"name":"TRAVERE THERAPEUTICS","description":"Pharmaceuticals","address_1":"3611 Valley Centre Drive","address_2":"Suite 300","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTOPHER PORTER","contact_telephone":"+1 877-969-7879","dt_updated":"2026-07-20T10:56:00.116563-04:00"},"client":{"id":200929,"url":"https://lda.gov/api/v1/clients/200929/","client_id":12,"name":"TRAVERE THERAPEUTICS","general_description":"Biopharmaceuticals","client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-08-15"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S.1040, to prohibit product hopping and for other purposes; proposals regarding patent thickets","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. HR 1518, the New Era of Preventing End-Stage Kidney Disease Act; end-stage renal disease policy and rare kidney disease","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"HR 946 and S. 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act); related provisions in H.R.1, One Big Beautiful Bill Act; Most Favored Nation and international reference pricing proposals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"HR 1262, S 932 Give Kids a Chance Act to renew PRV program; related provisions in H.R.1, One Big Beautiful Bill Act; HR 4709, the Newborn Screening Reauthorization Act; PDUFA/regulatory review process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Regulations regarding transparency, reimbursement and care, particularly regarding rare disease. Medicare and Medicaid related provisions in H.R.1, One Big Beautiful Bill Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1414, Cameron's Law to increase Orphan Drug Tax Credit to 50%; R&D tax credit; related implementation provisions in H.R.1, One Big Beautiful Bill Act; tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1418a58b-0775-4e45-9b77-06e8109c2656/","filing_uuid":"1418a58b-0775-4e45-9b77-06e8109c2656","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1418a58b-0775-4e45-9b77-06e8109c2656/print/","filing_document_content_type":"text/html","income":null,"expenses":"12210000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-04-20T13:06:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law No. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law No. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law No. 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No. 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Biopharmaceutical innovation policy issues SECURE Rx Act of 2026 (draft) User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2a724a0a-e0ad-4918-ac11-b31bc71cfd7c/","filing_uuid":"2a724a0a-e0ad-4918-ac11-b31bc71cfd7c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2a724a0a-e0ad-4918-ac11-b31bc71cfd7c/print/","filing_document_content_type":"text/html","income":null,"expenses":"299699.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-04-20T13:11:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e8e7b414-e066-4ab6-a68c-95ef70ab621c/","filing_uuid":"e8e7b414-e066-4ab6-a68c-95ef70ab621c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e8e7b414-e066-4ab6-a68c-95ef70ab621c/print/","filing_document_content_type":"text/html","income":null,"expenses":"600000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals","dt_posted":"2026-04-20T13:55:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12830 El Camino Real","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401105828,"url":"https://lda.gov/api/v1/registrants/401105828/","house_registrant_id":null,"name":"ACADIA PHARMACEUTICALS","description":"Biopharmaceutical company","address_1":"12830 El Camino Real","address_2":"Suite 400","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL MATTOON","contact_telephone":"+1 615-861-6000","dt_updated":"2026-07-27T17:33:39.420897-04:00"},"client":{"id":207583,"url":"https://lda.gov/api/v1/clients/207583/","client_id":12,"name":"ACADIA PHARMACEUTICALS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e8e7b414-e066-4ab6-a68c-95ef70ab621c/","filing_uuid":"e8e7b414-e066-4ab6-a68c-95ef70ab621c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e8e7b414-e066-4ab6-a68c-95ef70ab621c/print/","filing_document_content_type":"text/html","income":null,"expenses":"600000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals","dt_posted":"2026-04-20T13:55:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12830 El Camino Real","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401105828,"url":"https://lda.gov/api/v1/registrants/401105828/","house_registrant_id":null,"name":"ACADIA PHARMACEUTICALS","description":"Biopharmaceutical company","address_1":"12830 El Camino Real","address_2":"Suite 400","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL MATTOON","contact_telephone":"+1 615-861-6000","dt_updated":"2026-07-27T17:33:39.420897-04:00"},"client":{"id":207583,"url":"https://lda.gov/api/v1/clients/207583/","client_id":12,"name":"ACADIA PHARMACEUTICALS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cf6cd7a5-d6ee-4ed0-b861-047a616e7182/","filing_uuid":"cf6cd7a5-d6ee-4ed0-b861-047a616e7182","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/cf6cd7a5-d6ee-4ed0-b861-047a616e7182/print/","filing_document_content_type":"text/html","income":"450000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Krista Hessler Carver","dt_posted":"2026-04-20T16:12:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"850 Tenth Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":11195,"url":"https://lda.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":115000,"url":"https://lda.gov/api/v1/clients/115000/","client_id":467,"name":"PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64759,"prefix":null,"prefix_display":null,"first_name":"KRISTA","nickname":null,"middle_name":null,"last_name":"CARVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98248,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"DERZKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Biosimilars Access and Affordability Act (S. 5459); Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269); Expedited Access to Biosimilars Act (S. 1414); Biosimilar Red Tape Elimination Act (S. 1954/H.R. 5526); CLEAR Act (H.R.7140); Artificial Intelligence-Ready Data Act (S.4098); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); Drug Competition Enhancement Act (S.1040); America's Living Library Project Bill (S. 4023); Securing Essential Components for U.S. Readiness in Essential Pharmaceuticals (SECURE Rx) Act of 2026 (discussion draft); improvements to the National Childhood Vaccine Injury Act of 1986; Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act (S. 3788).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64759,"prefix":null,"prefix_display":null,"first_name":"KRISTA","nickname":null,"middle_name":null,"last_name":"CARVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":119967,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20900,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"L","last_name":"PLITSCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20743,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"F","last_name":"KINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98248,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"DERZKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69156,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"COSGROVE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2c1e2648-d1da-4d3b-8f42-38a6c89632e2/","filing_uuid":"2c1e2648-d1da-4d3b-8f42-38a6c89632e2","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2c1e2648-d1da-4d3b-8f42-38a6c89632e2/print/","filing_document_content_type":"text/html","income":null,"expenses":"5320000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Aron Griffin","dt_posted":"2026-04-20T18:16:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 PENNSYLVANIA AVENUE, NW, SOUTH BUILDING","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1581,"url":"https://lda.gov/api/v1/registrants/1581/","house_registrant_id":30629,"name":"AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)","description":null,"address_1":"601 PENNSYLVANIA AVENUE, NW, SOUTH BUILDING","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ARON GRIFFIN","contact_telephone":"+1 202-778-8461","dt_updated":"2026-07-30T15:46:39.601570-04:00"},"client":{"id":102632,"url":"https://lda.gov/api/v1/clients/102632/","client_id":12,"name":"AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - Rep. Arrington, Jodey - Medicare coverage of cancer screenings H.R. 935 - Health Care Workforce Innovation Act - Rep. Garbarino, Andrew - Increase behavioral health workforce H.R. 1096 - HOPE and Mental Wellbeing Act - Rep. Salinas, Andrea - Medicare primary care visit requirements H.R. 1407 - Permanent Telehealth from Home Act - Rep. Buchanan, Vern - Medicare telehealth coverage H.R. 1523 - PREVENT DIABETES Act - Rep. DeGette, Diana - Virtual prevention programs in Medicare H.R. 1614 - To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program. - Rep. Kelly, Mike - Expand practitioners eligible for telehealth in Medicare H.R. 1627 - TREATS Act - Rep. Norcross, Donald - telehealth SUD treatment H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology. - Rep. Hern, Kevin - Removing in-person requirements for Medicare coverage for mental health telehealth H.R. 1899 - Audio-Only Telehealth Access Act - Rep. Feenstra, Randy - Medicare coverage for audio-only telehealth H.R. 2013 - Medicare Home Health Accessibility Act - Rep. Smucker, Lloyd - Medicare coverage of home-based occupational therapy H.R. 2049 - Access to Family Building Act - Rep. Gillen, Laura - access to reproductive technology H.R. 2404 - Remote Opioid Monitoring Act - Rep. Balderson, Troy - remote monitoring for opioid prescriptions H.R. 2528 - Association Health Plans Act - Rep. Walberg, Tim - Association health plans treatment H.R. 2741 - PEER Support Act - Rep. Salinas, Andrea - Behavioral health workforce shortage H.R. 3000 - Caring for Seniors Act - Rep. Fitzpatrick, Brian - Long-term care workforce programs and cost reduction H.R. 4206 - CONNECT for Health Act - Rep. Thompson, Mike - Telehealth expansion and oversight H.R. 4484 - ADAPT Act - Rep. Balderson, Troy - Behavioral health service reimbursement for supervised trainees H.R. 5081 - Telehealth Modernization Act - Rep. Carter, Earl L. Buddy - Medicare telehealth flexibility extension H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 - Short term government funding bill; health care program funding H.R. 7064 - AI in Health Care Efficiency and Study Act - Rep. Hernandez, Pablo Jose - AI usage in health care H.R. 7537 - Corporate Crimes Against Health Care Act - Rep. Goodlander, Maggie - Private equity restrictions for health care industry H.R. 7787 - To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes. - Rep. Carter, Troy - Mental health professional workforce expansion H.R. 7790 - Medical Records Access Fairness Act - Rep. Foster, Bill - Requirements for providing protected health information to individuals S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - Sen. Crapo, Mike - Medicare coverage of cancer screenings S. 422 - Right to Contraception Act - Sen. Markey, Edward - Contraception and contraception services access S. 931 - COMPLETE Care Act - Sen. Cortez Masto, Catherine - Behavioral health integration S. 1056 - Home-Based Telemental Health Care Act - Sen. Rounds, Mike - mental health and SUD telehealth services S. 1227 - ABC Act - Sen. Markey, Edward - Family caregiver coverage paperwork S. 1261 - CONNECT for Health Act - Sen. Schatz, Brian - Telehealth expansion and oversight S. 1329 - PEER Support Act - Sen. Kaine, Tim - Behavioral health workforce shortage S. 1847 - Association Health Plans Act - Sen. Paul, Rand - Association health plans treatment S. 2356 - ADAPT Act - Sen. Barrasso, John - Behavioral health service reimbursement for supervised trainees S. 2709 - Telehealth Modernization Act - Sen. Scott, Tim - Medicare telehealth flexibility extension S. 3822 - Break Up Big Medicine Act - Sen. Warren, Elizabeth - Health care entity vertical integration restrictions S. 3829 - Corporate Crimes Against Health Care Act - Sen. Warren, Elizabeth - Private equity restrictions for health care industry S. 3834 - Expanded Telehealth Access Act - Sen. Daines, Steve - Medicare telehealth allowances Issues related to broadband and public health infrastructure; mental health and telehealth; behavioral health; rural health; substance use disorder treatments; Health Savings Accounts; provider directories; artificial intelligence and privacy; insurance industry response to and support for providers regarding the Change Healthcare cyberattack and broader cyber security issues; ACA Marketplace; ACA Marketplace Program Integrity; Mental Health Parity; Surprise Medical Billing; transparency; prior authorization; IVF Coverage; ACA market regulations; and vaccine coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43527,"prefix":null,"prefix_display":null,"first_name":"JEANETTE","nickname":null,"middle_name":null,"last_name":"THORNTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61321,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"HAMELBURG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67251,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":"S","last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68717,"prefix":null,"prefix_display":null,"first_name":"ARON","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71192,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DUGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113731,"prefix":null,"prefix_display":null,"first_name":"KELLEY","nickname":null,"middle_name":null,"last_name":"SCHULTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139720,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SHINE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142437,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143588,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143589,"prefix":null,"prefix_display":null,"first_name":"SOHINI","nickname":null,"middle_name":null,"last_name":"GUPTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144554,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146235,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"HAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146236,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TUFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Draft, Medicare Compare Website (no bill number) - Rep. Guthrie, Brett - improvements to CMS Medicare compare website H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 497 - Medicaid Third Party Liability Act - Rep. Crenshaw, Dan - Medicaid liable third-party exceptions H.R. 538 - Critical Access Hospital Relief Act - Rep. Smith, Adrian - Medicare physician certification requirement H.R. 584 - No Medicaid for Illegal Immigrants Act - Rep. Kiley, Kevin - Medicaid eligibility requirements H.R. 608 - COVER Now Act - Rep. Doggett, Lloyd - Medicaid expansion demo H.R. 610 - Close the Medigap Act - Rep. Doggett, Lloyd - Medigap plan reform H.R. 879 - Medicare Patient Access and Practice Stabilization Act - Rep. Murphy, Gregory - Medicare physician reimbursement H.R. 936 - Medicaid Improvement and State Flexibility Act - Rep. Green, Mark - Medicaid demonstration programs H.R. 1019 - Medicaid Program Improvement Act - Rep. Miller-Meeks, Mariannette - Medicaid management care reporting H.R. 1059 - Jobs and Opportunities for Medicaid Act - Rep. Crenshaw, Dan - Medicaid eligibility requirements H.R. 1162 - Medicaid Primary Care Improvement Act - Rep. Crenshaw, Dan - Medicaid direct primary care arrangements H.R. 1191 - Supporting Access to Rural Community Hospitals Act - Rep. Flood, Mike - Medicare critical access hospitals definition H.R. 1195 - Protect Medicaid Act - Rep. Hudson, Richard - Medicaid eligibility requirements H.R. 1279 - To amend title XIX of the Social Security Act to establish a community engagement requirement for certain individuals under the Medicaid program. - Rep. Bean, Aaron - Medicaid eligibility requirements H.R. 1403 - LIVE Beneficiaries Act - Rep. Bilirakis, Gus - Medicaid registration audits H.R. 1598 - Ensuring Access to Medicaid Buy-in Programs Act - Rep. Ciscomani, Juan - Medicaid eligibility requirements H.R. 1683 - Protecting Rural Seniors Access to Care Act - Rep. Fischbach, Michelle - Minimum nursing home staffing H.R. 1775 - Second Chances for Rural Hospitals Act - Rep. Arrington, Jodey -Definition of rural emergency hospitals H.R. 1805 - ARCH Act - Rep. Miller, Carol - Extend Medicare-dependent and low-value hospitals payments H.R. 1924 - Securing Access to Care for Seniors in Critical Condition Act - Rep. Hern, Kevin - Medicare site-neutral payments for LTC hospitals H.R. 2045 - Medicare Dental, Vision, and Hearing Benefit Act - Rep. Doggett, Lloyd - Medicare dental, vision, and hearing coverage H.R. 2263 - Telehealth Coverage Act - Rep. Khanna, Ro - Telehealth flexibilities in Medicare H.R. 2309 - Medicare and Medicaid Fraud Prevention Act - Rep. Peters, Scott - provider screening for Federal programs H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act - Rep. Green, Mark - Medicare Advantage prior authorization H.R. 2533 - EASE Act - Rep. Arrington, Jodey - CMS model for virtual technology H.R. 2586 - Reentry Act - Rep. Tonko, Paul - Medicaid coverage for incarcerated population H.R. 2590 - Mental and Physical Health Care Comorbidities Act - Rep. Boyle, Brendan - CMS demonstration to treat comorbidities H.R. 2610 - Protecting Options for Seniors Act - Rep. Tenney, Claudia - MA wage index reclassification H.R. 3023 - Preventing Hospital Overbilling of Medicare Act - Rep. Spartz, Victoria - Site-neutral payment reform H.R. 3069 - Medicare for All Act - Rep. Jayapal, Pramila - New national health insurance program H.R. 3222 - SMART Health Care Act - Rep. Spartz, Victoria - MA risk adjustment H.R. 3263 - PATCH Act - Rep. Tokuda, Jill - Medicare geographic practice cost indices H.R. 3321 - Ending Medicaid Discrimination Against the Most Vulnerable Act - Rep. Roy, Chip - Enhance FMAP phase out H.R. 3415 - Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act - Rep. Schakowsky, Janice - Nurse staffing ratio requirements H.R. 3467 - To amend title XVIII to reform the Medicare Advantage program - Rep. Schweikert, David - MA reforms H.R. 3808 - Expanding Seniors Access to Mental Health Services Act - Rep. Fitzpatrick, Brian - Medicare mental health services H.R. 4093 - Apples to Apples Comparison Act - Rep. Bean, Aaron - Medicare and Medicare Advantage spending reports H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4277 - Rural Emergency Hospital Financial Stability Act - Rep. Davis, Donald - Medicaid treatment of rural emergency hospitals H.R. 4313 - Hospital Inpatient Services Modernization Act - Rep. Buchanan, Vern - Acute hospital care at home waiver H.R. 4559 - Prompt and Fair Pay Act - Rep. Doggett, Lloyd - Payment parity for MA and FFS; MA reimbursement requirements H.R. 4641 - Keep Kids Covered Act - Rep. Castor, Kathy - Continuous eligibility for children in Medicaid/CHIP H.R. 4807 - Protect Our Hospitals Act - Rep. Landsman, Greg - Medicaid provider tax repeal H.R. 5243 - To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. - Rep. McClellan, Jennifer - MA supplemental benefits data reporting H.R. 5281 - REAL Health Providers Act - Rep. Panetta, Jimmy - MA provider directory requirements H.R. 5584 - Medicaid Third Party Liability Act - Rep. Burgess, Michael - Impact of Third Party Liability on MCOs H.R. 6109 - To amend title XVIII of the Social Security Act to establish certain requirements with respect to rates of reversed prior authorization coverage determinations under Medicare Advantage plans. - Rep. Pocan, Mark -prior authorization under Medicare Advantage H.R. 6110 -To amend title XVIII of the Social Security Act to require Medicare Advantage plans to automatically reconsider determinations denying coverage. - Rep. Pocan, Mark - reconsider denials under Medicare Advantage H.R. 6111 - To amend title XVIII of the Social Security Act to require any advertisement of a Medicare Advantage plan to include information related to the rates of prior authorization denials under such plan. - Rep. Pocan, Mark - advertise rates of prior authorization denials under Medicare Advantage H.R. 6112 - To amend title XVIII of the Social Security Act to establish certain requirements with respect to the average monthly cost to provide coverage to an enrollee under Medicare Advantage plans. - Rep. Pocan, Mark - require monthly coverage cost to enrollees under Medicare Advantage H.R. 6113 - To amend title XVIII of the Social Security Act to impose limitations on contracts with Medicare Advantage organizations offering multiple Medicare Advantage plans under the Medicare program. - Rep. Pocan, Mark - limit multiple Medicare Advantage plans H.R. 6114 - To prohibit funds made available to the Department of Health and Human Services by previous Appropriations Acts from being used for any activity that makes Medicare Advantage the default under the Medicare program. - Rep. Pocan, Mark - prohibit Medicare Advantage from becoming the default H.R. 6254 - Medicaid Staffing Flexibility and Protection Act of 2025 - Rep. Carter, Earl - extend eligibility determinations and redeterminations for Medicaid H.R. 6361 - Ban AI Denials in Medicare Act - Rep. Landsman, Greg - limit WISeR model H.R. 6951 - Stop Unfair Medicaid Recoveries Act - Rep. Schakowsky, Janice - State Medicaid cost recoupment H.R. 6974 - Improving MA SNP Act of 2026 - Rep. Arrington, Jodey - MA SNP beneficiary approval H.R. 7189 - PrEP Access Act - Rep. Pocan, Mark - HIV prevention services under Medicare H.R. 7409 - Defend Rural Health Act - Rep. Taylor, Dave - Medicare definition of rural hospital H.R. 7727 - Sustaining Rural Healthcare Act - Rep. Alford, Mark - Medicare CAH designation H.R. 7778 - Medicaid PNA Modernization Act - Rep. Subramanyam, Suhas - Medicaid minimum monthly personal needs allowance H.R. 7803 - Save Medicare Act - Rep. Pocan, Mark - Renames Medicare Advantage H.R. 7871 - MVP Act - Rep. Guthrie, Brett - Value-based purchasing arrangements in Medicaid S. 523 - Protect Medicaid Act - Sen. Cassidy, Bill - Medicaid eligibility requirements S. 678 - LIVE Beneficiaries Act - Sen. Scott, Rick - Medicaid enrollment audits S. 717 - Increasing Access to Quality Cardiac Rehabilitation Care Act - Sen. Capito, Shelley Moore - Expanding cardiac care coverage in Medicare S. 750 - Protecting Rural Seniors Access to Care Act - Sen. Fischer, Deb - Medicaid nursing home staff requirements S. 752 - Accelerating Kids Access to Care Act - Sen. Grassley, Chuck - Out-of-state provider access for Medicaid S. 939 - Medicare Dental, Hearing, and Vision Expansion Act - Sen. Sanders, Bernard - Medicare coverage requirements S. 1082 - Safeguarding Medicaid Act - Sen. Barrasso, John - Medicaid enrollee asset verification S. 1105 - No UPCODE Act - Sen. Cassidy, Bill - MA risk adjustment S. 1264 - Mental and Physical Health Care Comorbidities Act - Sen. Bennet, Michael - CMS demonstration to treat comorbidities S. 1399 - Health Tech Investment Act - Sen. Rounds, Mike - Medicare coverage for algorithm-based services S. 1506 - Medicare for All Act - Sen. Sanders, Bernard - New national health insurance program S. 1624 - PATCH Act - Sen. Schatz, Brian - Medicare geographic practice cost indices S. 1629 - Same Care, Lower Cost Act - Sen. Kennedy, John - Medicare site-neutral payment reform S. 1637 - MVP Act - Sen. Mullin, Markwayne - Medicaid value-based purchasing agreements S. 1709 - Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act - Sen. Padilla, Alex - Nurse staffing ratio requirements S. 1816 - Improving Seniors Timely Access to Care Act - Sen. Marshall, Roger - MA prior authorization S. 1903 - A bill to prohibit changes to Medicare and Medicaid in reconciliation - Sen. Reed, Jack - Medicare and Medicaid safeguards against reconciliation cuts S. 2237 - Hospital Inpatient Services Modernization Act - Sen. Scott, Tim - Acute hospital care at home waiver S. 2279 - Protect Medicaid and Rural Hospitals Act - Sen. Hawley, Josh - Medicaid provider tax and State directed payments S. 2289 - Healthy Moms and Babies Act - Sen. Grassley, Chuck - Medicaid/CHIP maternal health coverage improvements S. 2496 - Keep Kids Covered Act - Sen. Bennet, Michael - Continuous eligibility for children in Medicaid/CHIP S. 2497 - Fair Billing Act - Sen. Hassan, Maggie - Medicare site-neutral transparency and identification requirements S. 2556 - Protecting Healthcare and Lowering Costs Act - Sen. Schumer, Charles - repeal of Medicaid provisions in the One Big Beautiful Bill Act S. 2793 - Ensuring Access to Essential Providers Act - Sen. Cassidy, Bill - Essential community provider coverage requirements for MA S. 3642 - WALZ Act - Sen. Marshall, Roger - Medicaid payment investigation and audits S. 3690 - Ensuring Access to Medicaid Buy-in Programs - Sen. Blackburn, Marsha - Medicaid eligibility parameters S. 3727 - Putting an N to Learing about Fraud Act - Sen. Ernst, Joni - Federal program fraud prevention S. 3729 - PBM Reporting Transparency Act - Sen. Warner, Mark - MedPAC reports on PBMs S. 3750 - REAL Health Providers Act - Sen. Bennet, Michael - MA provider directory accuracy S. 3762 - Prior Authorization Relief Act - Sen. Whitehouse, Sheldon - MA prior authorization restrictions S. 3848 - Apples to Apples Comparison Act - Sen. Scott, Tim - Medicare and Medicare Advantage spending reports S. 3886 - Nurses Belong in Nursing Homes Act - Sen. Wyden, Ron - Nursing home staffing hours Issues related to mental health and Medicare; Medicare and Medicaid funding; Medicaid expansion; State innovation waivers; Medicaid and CHIP; Medicaid FMAP; Medicare Supplement Coverage; Medicare Transparency in Coverage; Medicaid Access Final Rule; Medicaid Redeterminations; Medicaid rate actuarial soundness; value of Medicaid Managed Care; value of Medicare Advantage; Medicare Advantage Health Risk Assessment and chart reviews; Medicare Advantage supplemental benefits and Social Determinants of health; CBO estimates of MA and FFS costs; coverage of weight loss drugs; Inflation Reduction Act implementation; Medicare Advantage Rate Notice; Part D Payment Issues; Part D VBID Issues; RADV; MA payment issues; Part D issues; prior authorization; MA prompt pay; agent/broker issues; implementation of the One Big Beautiful Bill Act; provider taxes; Medicaid community engagement requirements; and VAs community care program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":113731,"prefix":null,"prefix_display":null,"first_name":"KELLEY","nickname":null,"middle_name":null,"last_name":"SCHULTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139720,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SHINE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142437,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143588,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143589,"prefix":null,"prefix_display":null,"first_name":"SOHINI","nickname":null,"middle_name":null,"last_name":"GUPTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144554,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146235,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"HAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146236,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TUFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149902,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"DUNBAR-HESTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":43527,"prefix":null,"prefix_display":null,"first_name":"JEANETTE","nickname":null,"middle_name":null,"last_name":"THORNTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61321,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"HAMELBURG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68717,"prefix":null,"prefix_display":null,"first_name":"ARON","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71192,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DUGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Draft, To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require out- of-pocket expenditures for drugs to count towards an individuals deductible and out-of-pocket maximum. (no bill number) - Rep. Murphy, Greg - Requirements for deductibles and MOOP to include expenditures for DTC prescriptions H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 90 - Health Coverage Choice Act - Rep. Biggs, Andy - Duration of STLDHI plans H.R. 114 - Responsible Path to Full Obamacare Repeal Act - Rep. Biggs, Andy - ACA repeal H.R. 247 - Health Care Affordability Act - Rep. Underwood, Lauren - ACA tax credit extension H.R. 267 - Health Care Price Transparency Act - Rep. Davidson, Warren - Hospital and insurer transparency requirements H.R. 639 - Doctor Knows Best Act - Rep. Van Drew, Jefferson - Commercial market prior authorization H.R. 957 - Parity Enforcement Act - Rep. Norcross, Donald - Penalties for mental health parity violations H.R. 1385 - DOC Access Act - Rep. Carter, Earl Buddy - Rate setting for dental and optometric services H.R. 1397 - Increasing Access to Dental Insurance Act - Rep. Miller-Meeks, Mariannette - Standalone dental plans H.R. 1776 - New Health Options Act - Rep. Palmer, Gary - ACA reinsurance H.R. 2079 - Insurance Fraud Accountability Act - Rep. Ross, Deborah - fraudulent ACA enrollments H.R. 2199 - Restore Protections for Dialysis Patients Act - Rep. Kelly, Mike - ESRD coverage H.R. 2553 - Capping Prescription Costs Act - Rep. Horsford, Steven - Prescription cost-sharing H.R. 2554 - Lower Drug Costs for Families Act - Rep. Horsford, Steven - Commercial market drug rebates H.R. 2636 - Making Insulin Affordable for All Children Act - Rep. Landsman, Greg - Commercial market insulin cost-sharing H.R. 3020 - Addressing Anti-Competitive Health Care Contract Clauses Act - Rep. Spartz, Victoria - Study on anti-competitive contracting H.R. 3527 - Bridge to Medicaid Act - Rep. Sewell, Terri - ACA subsidies for non-Medicare expansion states H.R. 3701 - Family Vaccine Protection Act - Rep. Pallone, Frank - ACIP codification and vaccine coverage H.R. 4406 - State-Based Universal Health Care Act - Rep. Khanna, Ro - State-based universal health care H.R. 4710- No Surprises Act Enforcement Act - Rep. Murphy, Greg - Surprise billing penalties for noncompliance by health insurers H.R. 5145 - Bipartisan Premium Tax Credit Extension Act - Rep. Kiggans, Jennifer - Temporary extension of ACA enhanced premium tax credits H.R. 6171 - ACA Copay CAP Act of 2025 - Rep. Auchincloss, Jake - establish out of pocket limit on prescription drugs H.R. 6248 - Healthy Competition for Better Care Act - Rep. Arrington, Jodey - ban anticompetitive terms in contracts, promote higher quality, lower cost care H.R. 6703 - Lower Health Care Premiums for All Americans Act - Rep. Miller-Meeks, Mariannette - amend ERISA to lower premiums H.R. 7023 - Affordable CHOICE Act - Rep. Schakowsky, Janice - public option under ACA H.R. 7164 - Capping Costs for Consumers Act - Rep. Schrier, Kim - ACA cost-sharing reductions S. 46 - Health Care Affordability Act - Sen. Shaheen, Jeanne - ACA tax credit extension S. 729 - Hospital Transparency Compliance Enforcement Act - Sen. Kennedy, John - Hospital price transparency requirements S. 864 - HELP Copays Act - Sen. Marshall, Roger - Cost-sharing requirements S. 976 - Insurance Fraud Accountability Act - Sen. Wyden, Ron - fraudulent ACA enrollments S. 2355 - Patients Deserve Price Tags Act - Sen. Marshall, Roger - Hospital and insurer price transparency requirements S. 2420 - No Surprises Act Enforcement Act - Rep. Marshall, Roger - Surprise billing penalties for noncompliance by health insurers S. 2824 - A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium tax credits - Sen. Murkowski, Lisa - Temporary extension of ACA enhanced premium tax credits S. 3599 - Affordable CHOICE Act - Sen. Whitehouse, Sheldon - public option under ACA S. 3990 - PrEP Access and Coverage Act - Sen. Smith, Tina - Coverage requirements for HIV services Issues related to implementation rule implementing the No Surprises Act prohibiting surprise medical bills; transparency report requirements; parity in mental health benefits; ERISA preemption; paperless delivery for health plan disclosures; Unauthorized Enrollments/Unauthorized Plan Switching; ACA Tax Credits (Inflation Reduction Act); final rule on Section 1557 of the ACA and its impact on Medigap plans; ACA Marketplace Enrollment and Agents and Brokers; Vaccine Coverage; Preventative Services Coverage; the Advanced Explanation of Benefits; coverage of weight loss drugs; Transparency in Coverage; No Surprises Act; ACA Marketplace Integrity; ACA Enhanced Tax Credits; Prior Authorization; health savings accounts; and potential changes to the VA community care program, including administration of community care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43527,"prefix":null,"prefix_display":null,"first_name":"JEANETTE","nickname":null,"middle_name":null,"last_name":"THORNTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67251,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":"S","last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68717,"prefix":null,"prefix_display":null,"first_name":"ARON","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61321,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"HAMELBURG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71192,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DUGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113731,"prefix":null,"prefix_display":null,"first_name":"KELLEY","nickname":null,"middle_name":null,"last_name":"SCHULTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139720,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SHINE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142437,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143588,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143589,"prefix":null,"prefix_display":null,"first_name":"SOHINI","nickname":null,"middle_name":null,"last_name":"GUPTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144554,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146235,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"HAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146236,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TUFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Draft, Expedited Access to Biosimilars Act (no bill number) - Rep. Langworthy, Nick - Biosimilar approval requirements H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Generic drugs applications and approvals H.R. 946 - ORPHAN Cures Act - Rep. Joyce, John - Medicare Drug Negotiation Program H.R. 950 - Saving Seniors Money on Prescriptions Act - Rep. Landsman, Greg - PBM reporting requirements for MA/Part D plans. H.R. 1117 - Responsibility in Drug Advertising Act - Rep. DeLauro, Rosa - Direct-to-consumer ads H.R. 1244 - Reducing Drug Prices for Seniors Act - Rep. Davis, Donald - Coinsurance for Part D drugs H.R. 2214 - DRUG Act - Rep. Miller-Meeks, Mariannette - PBM contracts H.R. 2450 - Prescription Drug Transparency and Affordability Act - Rep. McDonald Rivet, Kristen - PBM transparency H.R. 3493 - Global Fairness in Drug Pricing Act - Rep. Khanna, Ro - Prescription drug international reference pricing H.R. 3546 - Prescription Drug Price Relief Act - Rep. Khanna, Ro - Prescription drug patent reform H.R. 3775 - Fair Prescription Drug Prices for Americans Act - Rep. Van Drew, Jefferson - Prescription drug and biological product international reference pricing H.R. 3789 - DTC Act - Rep. Taylor, David - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparency requirements for DTC drug ads H.R. 5094 - Protect Patients from Costly Care Act - Rep. Pappas, Chris - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program H.R. 5197 - Protect Beneficiaries from Middlemen Act - Rep. Malliotakis, Nicole - Medicare cost-sharing limit for drugs H.R. 6255 - Affordable Insulin Now Act - Rep. Craig, Angie - require cost-sharing for certain insulin products H.R. 7837 - Most Favored Patient Act - Rep. Meuser, Daniel - MFN demonstration S. 229 - DTC Act - Sen. Durbin, Richard - Drug advertising requirements S. 483 - Responsibility in Drug Advertising Act - Sen. King, Angus - Drug advertising requirements S. 526 - Pharmacy Benefit Manager Transparency Act of 2025 - Sen. Grassley, Chuck - PBM reporting requirements S. 529 - Capping Prescription Costs Act - Sen. Warnock, Raphael - Drug copay caps S. 652 - Protecting Patients from Deceptive Drugs Ads Act - Sen. Durbin, Richard - Drug advertising requirements S. 882 - Patients Before Middlemen Act - Sen. Blackburn, Marsha - PBM reforms S. 891 - Bipartisan Health Care Act - Sen. Wyden, Ron - PBM reforms and transparency S. 1040 - Drug Competition Enhanced Act - Sen. Cornyn, John - Drug patent reform S. 1041 - Affordable Prescriptions for Patients Act - Sen. Cornyn, John - Patent issues S. 1095 - Stop STALLING Act - Sen. Klobuchar, Amy - Drug patent reform S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - Drug patent reform S. 1414 - Expedited Access to Biosimilars Act - Sen. Paul, Rand - Biosimilars assessment and approval S. 1587 - Fair Prescription Drug Prices for Americans Act - Sen. Hawley, Josh - Prescription drug international reference pricing S. 1753 - End Price Gouging for Medications Act - Sen. Merkley, Jeff - Prescription drug international reference pricing S. 1818 - Prescription Drug Price Relief Act - Sen. Sanders, Bernard - Prescription drug patent reform S. 1954 - Biosimilar Red Tape Elimination Act - Sen. Lee, Mike - Biological product assessment and approval S. 1973 - Treat and Reduce Obesity Act - Sen. Cassidy, Bill - Medicare coverage for obesity drugs S. 2345 - Short on Competition Act - Sen. Klobuchar, Amy - Expedited approval for generic drugs S. 2447 - Repealing the Trump Sick Tax Act - Sen. Welch, Peter - Repeal of Medicaid cost sharing requirements for drugs; Orphan drug inclusion in Medicare Drug Price Negotiation Program S. 2620 - REMEDY Act - Sen. Durbin, Richard - Expedited approvals for certain drug approvals Issues related to the implementation of Inflation Reduction Act - Medicare negotiation; cost-sharing and coverage of weight loss drugs/GLP-1s; high priced drugs; patent reforms; Pharmacy Benefit Managers; PBM related issues; and copay coupons.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61321,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"HAMELBURG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68717,"prefix":null,"prefix_display":null,"first_name":"ARON","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":43527,"prefix":null,"prefix_display":null,"first_name":"JEANETTE","nickname":null,"middle_name":null,"last_name":"THORNTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71192,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DUGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139720,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SHINE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142437,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113731,"prefix":null,"prefix_display":null,"first_name":"KELLEY","nickname":null,"middle_name":null,"last_name":"SCHULTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143588,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143589,"prefix":null,"prefix_display":null,"first_name":"SOHINI","nickname":null,"middle_name":null,"last_name":"GUPTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144554,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146235,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"HAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146236,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TUFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - One Big Beautiful Bill Act - Rep. Arrington, Jodey - Medicaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 127 - Protection from Obamacare Mandates and Congressional Equity Act - Rep. Biggs, Andy - Repeals IRS mandate on minimum essential coverage H.R. 247 - Health Care Affordability Act - Rep. Underwood, Lauren - ACA tax credit extension H.R. 379 - Healthcare Freedom and Choice Act - Rep. Carter, Earl Buddy - Duration of STLDHI plans H.R. 1157 - ACCESS Act - Rep. Steube, Gregory - HSA contributions H.R. 2571 - Self-Insurance Protection Act - Rep. Onder, Robert - Medical stop loss coverage definition H.R. 3080 - Health Care Fairness for All Act - Rep. Sessions, Pete - Health savings accounts H.R. 5145 - Bipartisan Premium Tax Credit Extension Act - Rep. Kiggans, Jennifer - Temporary extension of ACA enhanced premium tax credits H.R. 6010 - To amend the Internal Revenue Code of 1986 to extend and modify the enhanced premium tax credit, and for other purposes. - Rep. Liccardo, Sam - extend enhanced premium tax credit H.R. 6232 - HOPE Act - Rep. Suozzi, Tom - extend the enhanced premium tax credit S. 2641 - Health Care Freedom and Choice Act - Sen. Johnson, Ron - Duration of STLDHI plans S. 2824 - A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium tax credits - Sen. Murkowski, Lisa - Temporary extension of ACA enhanced premium tax credits S. 3751 - Prescription Drug Supply Chain Pricing Transparency Act - Sen. Bennet, Michael - Prescription drug supply chain price transparency report Issues related to the employer health insurance tax exclusion.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43527,"prefix":null,"prefix_display":null,"first_name":"JEANETTE","nickname":null,"middle_name":null,"last_name":"THORNTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67251,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":"S","last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68717,"prefix":null,"prefix_display":null,"first_name":"ARON","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71192,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"DUGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139720,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SHINE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142437,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"BECK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143589,"prefix":null,"prefix_display":null,"first_name":"SOHINI","nickname":null,"middle_name":null,"last_name":"GUPTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144554,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146235,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"HAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146236,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TUFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2c5d0123-1385-41b5-aa02-7303db5efcbf/","filing_uuid":"2c5d0123-1385-41b5-aa02-7303db5efcbf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2c5d0123-1385-41b5-aa02-7303db5efcbf/print/","filing_document_content_type":"text/html","income":null,"expenses":"1640000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-04-20T21:36:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (P.L. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75), Provisions related to the pharmaceutical industry. Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: H.R. 1492, Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Section 340B Public Health Services Act 340B engagement and MFN related engagement Provisions related to the 340B program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Biopharmaceutical innovation and pricing issues HR 5509, Safe Step Act, Provisions related step therapy protocols Tariff and MFN issues VICP Bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/dcd60574-b063-479a-829c-a06ed09e9219/","filing_uuid":"dcd60574-b063-479a-829c-a06ed09e9219","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/dcd60574-b063-479a-829c-a06ed09e9219/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Thomas Worrall, Partner","dt_posted":"2026-04-21T10:25:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 H Street, NW","registrant_address_2":"Suite 525","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":292892,"url":"https://lda.gov/api/v1/registrants/292892/","house_registrant_id":37346,"name":"WHITMER & WORRALL, LLC","description":"A government relations and consulting firm.","address_1":"1401 H Street, NW","address_2":"Suite 525","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARTIN WHITMER","contact_telephone":"+1 202-558-6000","dt_updated":"2026-07-22T13:56:32.152773-04:00"},"client":{"id":57911,"url":"https://lda.gov/api/v1/clients/57911/","client_id":57911,"name":"CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)","general_description":"Coalition to promote lowering prescription drug prices.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-11-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren; Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1ffec1b7-a7af-4b72-b683-9783c231beb4/","filing_uuid":"1ffec1b7-a7af-4b72-b683-9783c231beb4","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1ffec1b7-a7af-4b72-b683-9783c231beb4/print/","filing_document_content_type":"text/html","income":null,"expenses":"2996995.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-04-21T12:15:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/4ebc8da1-b3f2-4f07-89b4-e0518e9bb822/","filing_uuid":"4ebc8da1-b3f2-4f07-89b4-e0518e9bb822","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/4ebc8da1-b3f2-4f07-89b4-e0518e9bb822/print/","filing_document_content_type":"text/html","income":null,"expenses":"47670.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Steve Issenman","dt_posted":"2026-07-15T11:58:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"10 W. Lafayette Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Trenton","registrant_state":"NJ","registrant_zip":"08608","registrant":{"id":75251,"url":"https://lda.gov/api/v1/registrants/75251/","house_registrant_id":36035,"name":"HEALTHCARE INSTITUTE OF NEW JERSEY","description":"government affairs for biopharmaceutical and medical device trade association","address_1":"10 W. Lafayette Street","address_2":null,"address_3":null,"address_4":null,"city":"Trenton","state":"NJ","state_display":"New Jersey","zip":"08608","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVE ISSENMAN","contact_telephone":"+1 732-729-9619","dt_updated":"2026-07-15T15:26:57.674024-04:00"},"client":{"id":167699,"url":"https://lda.gov/api/v1/clients/167699/","client_id":12,"name":"HEALTHCARE INSTITUTE OF NEW JERSEY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-12-08"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Generally promoting awareness of the biopharmaceutical and medical technology sectors. Generally opposing the imposition of price controls in the Medicare Part D program or elsewhere. Generally supporting intellectual property rights. Generally opposing various legislative and executive efforts to impose an international price index. Generally promoting awareness of increasing antimicrobial/antifungal resistance. Supporting the extension of the SBIR program. Generally supporting changes to the 340B program. Generally supporting efforts to require pharmacy benefit managers (PBMs) to pass on rebates to patients. Raising awareness within Congressional offices about Ethylene Oxide and EPA proposed regulations. Opposing proposed FTC changes to non-compete clauses. Supporting the restoration of the orphan drug tax credit (Cameron's Law, H.R. 1414). Supporting the modernization of prescribing information to allow digital in lieu of printed information, H.R. 4132 and S. 2027. Supporting Ensuring Patient Access to Critical Breakthrough Products Act/MCET (H.R. 1691 in the previous Congress). Supporting the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369 in the previous Congress). Supporting the Saving Access to Laboratory Services (SALSA) Act (H.R. 2377 in the previous Congress). Supporting the Protecting Patients Against PBM Abuses Act (H.R. 2880 in the previous Congress). Supporting the PASTEUR Act (H.R. 2940 and S. 1355 in the previous Congress). Supporting the Treat And Reduce Obesity Act (H.R. 4818, S. 2407 in the previous Congress). Supporting the Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 5391 and S. 2764 in the previous Congress). Supporting the Rare Pediatric Disease Priority Review Voucher Act (H.R. 1262 and S. 932). Supporting the Maintaining Investments in New Innovation (MINI) Act (H.R. 1672). Supporting the Delinking Revenue from Unfair Gouging (DRUG) Act (H.R. 6283 in the previous Congress). Supporting changes to the small molecule portions of the Inflation Reduction Act (H.R. 1492 and S. 832). Supporting \"cap and smooth\" efforts within the Inflation Reduction Act's cap on out-of-pocket expenses. Opposing pricing policies related to \"Most Favored Nation\" proposals and indexing to international prices. Opposing tariffs on pharmaceutical and medical device products. Opposing CMSs proposed interpretation of a Qualifying Single Source Drug (QSSD). Generally providing thoughts on federal data privacy transparency and security policies. Submitting comments opposing proposed changes to bona fide fee structures. Generally opposing CMMI's demonstration project on prior authorization in the Medicare program. Supporting the RESULTS Act, HR 5269 and S.2761. Opposing CMS GUARD and GLOBE pricing model proposals. Opposing HR 3375 and S 1587, \"Most Favored Nation\" legislation. Supporting the PBM FAIR Act, H.R. 68937 and S. 3549. Generally raising awareness of vaccine efficacy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45619,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"ISSENMAN","suffix":null,"suffix_display":null},"covered_position":"Cong. Page (87-88), Congressional Aide (1990's)","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ab61f2b1-d8bc-4913-a5ae-fdfce0c8fbe2/","filing_uuid":"ab61f2b1-d8bc-4913-a5ae-fdfce0c8fbe2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ab61f2b1-d8bc-4913-a5ae-fdfce0c8fbe2/print/","filing_document_content_type":"text/html","income":null,"expenses":"1200000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Samantha Ventimiglia","dt_posted":"2026-07-16T11:05:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"50 Northern Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02210","registrant":{"id":40027242,"url":"https://lda.gov/api/v1/registrants/40027242/","house_registrant_id":39888,"name":"VERTEX PHARMACEUTICALS INCORPORATED","description":"Global biotechnology company","address_1":"50 Northern Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02210","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SAMANTHA VENTIMIGLIA","contact_telephone":"+1 202-264-3511","dt_updated":"2026-07-29T12:53:27.346758-04:00"},"client":{"id":188223,"url":"https://lda.gov/api/v1/clients/188223/","client_id":48,"name":"VERTEX PHARMACEUTICALS INCORPORATED","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":10,"name":"Vice President of the U.S."},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Corporate tax reform; H.R. 1414 - Cameron's Law, Preservation of Orphan Drug Tax Credit.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Education about non-opioid pain therapies and patient access to non-opioid medicines, updates on coverage progress at the VHA and CMS.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153466,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"HILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to the Defense Health Agency and service member access to non-opioid alternatives, including reinstating the DHA Benefits Advisory Panel and the structured formulary management process.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DOC","general_issue_code_display":"District of Columbia","description":"Issues related to Sec. 232 pharmaceutical tariffs, onshoring active pharmaceutical ingredients (API), and supply chain disruptions for products related to the opioid public health emergency.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/77618e47-b2ef-4cfa-9896-f031126d61c1/","filing_uuid":"77618e47-b2ef-4cfa-9896-f031126d61c1","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/77618e47-b2ef-4cfa-9896-f031126d61c1/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Annie Kennedy","dt_posted":"2026-07-17T11:34:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1012 14th NW, Suite 500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106105,"url":"https://lda.gov/api/v1/registrants/401106105/","house_registrant_id":null,"name":"RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)","description":"Nonprofit, nonpartisan organization dedicated to empowering rare disease patient community","address_1":"1012 14th NW, Suite 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNIE KENNEDY","contact_telephone":"+1 202-697-7273","dt_updated":"2026-10-16T13:50:48.525272-04:00"},"client":{"id":210900,"url":"https://lda.gov/api/v1/clients/210900/","client_id":12,"name":"RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 822, H.R. 1532 - Scientific EXPERT Act of 2025; H.R. 4709 - Newborn Screening Saves Lives Reauthorization Act of 2025; FY 2027 Appropriations; FDA user fee reauthorization; H.R. 7118 - Genomic Answers for Children's Health Act; H.R. 5509, S. 2903 - Safe Step Act; H.R. 1414 - Cameron's Law","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":101949,"prefix":null,"prefix_display":null,"first_name":"JAMIE","nickname":null,"middle_name":null,"last_name":"SULLIVAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101951,"prefix":null,"prefix_display":null,"first_name":"DYLAN","nickname":null,"middle_name":null,"last_name":"SIMON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/70494441-3fb4-4099-829b-ffd9b717efe3/","filing_uuid":"70494441-3fb4-4099-829b-ffd9b717efe3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/70494441-3fb4-4099-829b-ffd9b717efe3/print/","filing_document_content_type":"text/html","income":null,"expenses":"140000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christopher Porter","dt_posted":"2026-07-20T08:09:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3611 Valley Centre Drive","registrant_address_2":"Suite 300","registrant_different_address":true,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401104190,"url":"https://lda.gov/api/v1/registrants/401104190/","house_registrant_id":null,"name":"TRAVERE THERAPEUTICS","description":"Pharmaceuticals","address_1":"3611 Valley Centre Drive","address_2":"Suite 300","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTOPHER PORTER","contact_telephone":"+1 877-969-7879","dt_updated":"2026-07-20T10:56:00.116563-04:00"},"client":{"id":200929,"url":"https://lda.gov/api/v1/clients/200929/","client_id":12,"name":"TRAVERE THERAPEUTICS","general_description":"Biopharmaceuticals","client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-08-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. HR 1518, the New Era of Preventing End-Stage Kidney Disease Act; end-stage renal disease policy and rare kidney disease","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"HR 946 and S. 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act); related provisions in H.R.1, One Big Beautiful Bill Act; Most Favored Nation and international reference pricing proposals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"HR 1262, S 932 Give Kids a Chance Act to renew PRV program; related provisions in H.R.1, One Big Beautiful Bill Act; HR 4709, the Newborn Screening Saves Lives Reauthorization Act; PDUFA/regulatory review process; H.R. 9102, Biotech Investment National Security Act (BINSA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Regulations regarding transparency, reimbursement and care, particularly regarding rare disease. Medicare and Medicaid related provisions in H.R.1, One Big Beautiful Bill Act.H.R. 9509, the Kidney Disease Education Expansion Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S.1040, to prohibit product hopping and for other purposes; proposals regarding patent thickets. S. 2658, Medication Affordability and Patent Integrity Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1414, Cameron's Law to increase Orphan Drug Tax Credit to 50%; R&D tax credit; related implementation provisions in H.R.1, One Big Beautiful Bill Act; pharmaceutical tariffs, specifically related to orphan drugs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f58b4bde-7938-47fb-836d-c4d1337d5db9/","filing_uuid":"f58b4bde-7938-47fb-836d-c4d1337d5db9","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/f58b4bde-7938-47fb-836d-c4d1337d5db9/print/","filing_document_content_type":"text/html","income":null,"expenses":"180000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cate McCanless","dt_posted":"2026-07-20T11:28:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"630 W Germantown Pike","registrant_address_2":"Suite 215","registrant_different_address":false,"registrant_city":"Plymouth Meeting","registrant_state":"PA","registrant_zip":"19462","registrant":{"id":401105020,"url":"https://lda.gov/api/v1/registrants/401105020/","house_registrant_id":null,"name":"HARMONY BIOSCIENCES","description":"pharmaceuticals","address_1":"630 W Germantown pike","address_2":"Suite 215","address_3":null,"address_4":null,"city":"plymouth meeting","state":"PA","state_display":"Pennsylvania","zip":"19462","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CATE MCCANLESS","contact_telephone":"+1 202-420-7888","dt_updated":"2026-07-30T13:20:38.186535-04:00"},"client":{"id":203037,"url":"https://lda.gov/api/v1/clients/203037/","client_id":12,"name":"HARMONY BIOSCIENCES","general_description":"pharmaceuticals","client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-03"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 3019 - No Big Blockbuster Bailouts Act (NOBBBA) Cameron's Law (HR 1414) EPIC Act (HR 1492, S 832) HR 1672 Maintaining Investments in New Innovation Act Issues related to protecting patient access to medicines Issues related to protecting orphan drug policies Issues related to most-favored-nation policies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146555,"prefix":"ms","prefix_display":"MS.","first_name":"SUSANNA","nickname":null,"middle_name":"AGUIRRE","last_name":"HASTINGS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69985,"prefix":null,"prefix_display":null,"first_name":"CATE","nickname":null,"middle_name":null,"last_name":"MCCANLESS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5ad8f848-d4e0-4bdf-b014-99812a46595b/","filing_uuid":"5ad8f848-d4e0-4bdf-b014-99812a46595b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5ad8f848-d4e0-4bdf-b014-99812a46595b/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals","dt_posted":"2026-07-20T12:28:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12830 El Camino Real","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401105828,"url":"https://lda.gov/api/v1/registrants/401105828/","house_registrant_id":null,"name":"ACADIA PHARMACEUTICALS","description":"Biopharmaceutical company","address_1":"12830 El Camino Real","address_2":"Suite 400","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL MATTOON","contact_telephone":"+1 615-861-6000","dt_updated":"2026-07-27T17:33:39.420897-04:00"},"client":{"id":207583,"url":"https://lda.gov/api/v1/clients/207583/","client_id":12,"name":"ACADIA PHARMACEUTICALS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"BINSA Act, H.R. 9102.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5ad8f848-d4e0-4bdf-b014-99812a46595b/","filing_uuid":"5ad8f848-d4e0-4bdf-b014-99812a46595b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5ad8f848-d4e0-4bdf-b014-99812a46595b/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals","dt_posted":"2026-07-20T12:28:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12830 El Camino Real","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401105828,"url":"https://lda.gov/api/v1/registrants/401105828/","house_registrant_id":null,"name":"ACADIA PHARMACEUTICALS","description":"Biopharmaceutical company","address_1":"12830 El Camino Real","address_2":"Suite 400","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL MATTOON","contact_telephone":"+1 615-861-6000","dt_updated":"2026-07-27T17:33:39.420897-04:00"},"client":{"id":207583,"url":"https://lda.gov/api/v1/clients/207583/","client_id":12,"name":"ACADIA PHARMACEUTICALS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"BINSA Act, H.R. 9102.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a295baed-9f37-4626-856c-d456b0735d7b/","filing_uuid":"a295baed-9f37-4626-856c-d456b0735d7b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/a295baed-9f37-4626-856c-d456b0735d7b/print/","filing_document_content_type":"text/html","income":null,"expenses":"1680000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Katie Jones","dt_posted":"2026-07-20T13:24:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1800 CONCORD PIKE, P.O. BOX 15437","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WILMINGTON","registrant_state":"DE","registrant_zip":"19850","registrant":{"id":54073,"url":"https://lda.gov/api/v1/registrants/54073/","house_registrant_id":34975,"name":"ASTRAZENECA PHARMACEUTICALS LP","description":null,"address_1":"1800 CONCORD PIKE, P.O. BOX 15437","address_2":null,"address_3":null,"address_4":null,"city":"WILMINGTON","state":"DE","state_display":"Delaware","zip":"19850","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMIE BELL","contact_telephone":"+1 202-246-7003","dt_updated":"2026-07-23T13:13:46.789950-04:00"},"client":{"id":158571,"url":"https://lda.gov/api/v1/clients/158571/","client_id":12,"name":"ASTRAZENECA PHARMACEUTICALS LP","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DE","state_display":"Delaware","country":"US","country_display":"United States of America","ppb_state":"DE","ppb_state_display":"Delaware","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S 1637 MVP Act and Medicaid VBPs for Patients S 2903 / HR 5509 Safe Step Act HR 946/S 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures) Act HR 3521 / S 4440 Clinical Trial Modernization Act HR 7118 Genomic Answers for Childrens Health Act Clinical Trials Modernization Act CMMI GENEROUS Demo FDA modernization policy Implementation of the Inflation Reduction Act (IRA) -- with specific focus on drug negotiation (orphan drug exemption language) BIOSECURE Act implementation Issues related to the Medicare title in the One Big Beautiful Bill Act Issues related to the IRA definition of a drug for purposes of price negotiation selection Duplicate discounts as required by IRA Issues related to expanding/amending the orphan drug exclusion in IRA Issues related to pharmacy benefit manager (PBM) reform Issues related to mitigation of 340B Issues related to 340B Rebate Model Pilot Program for IRA compliance Issues related to the US manufacturing of pharmaceuticals Issues related to the development of novel therapies including cell therapy and antibody drug conjugates (ADCs) Issues related to the recruitment of patients for clinical trials Issues related to most-favored nations drug pricing proposals General issues related to rare disease and orphan drugs Policies related to international reference pricing for pharmaceuticals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141479,"prefix":"mrs","prefix_display":"MRS.","first_name":"SARAH","nickname":null,"middle_name":"CUDWORTH","last_name":"ARBES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73220,"prefix":null,"prefix_display":null,"first_name":"CAROLINE","nickname":null,"middle_name":null,"last_name":"QUAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147851,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"LANGENDERFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154501,"prefix":null,"prefix_display":null,"first_name":"TALEEN","nickname":null,"middle_name":null,"last_name":"MEKHDJAVAKIAN","suffix":null,"suffix_display":null},"covered_position":"Senator Bill Nelson, FL: Staff Assistant: 2010-2012 Scheduler: 2013-2015 Legislative Correspondent: 2015-2016 Legislative Aide: 2016-2018","new":true},{"lobbyist":{"id":154701,"prefix":"ms","prefix_display":"MS.","first_name":"BAILEY","nickname":null,"middle_name":"LAUREN","last_name":"MCCUE","suffix":null,"suffix_display":null},"covered_position":"Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021 Senator John Cornyn - Legislative Aide April 2022-December 2022 Senator John Boozman - Legislative Assistant, December 2022-February 2025","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 9599 The SECURE 340B Act Pharmaceutical supply chain manufacturing Policies related to the use of international reference pricing in Medicare/Medicaid 340B rebate model Part B and Part D drugs Medicare drug price negotiation Medicare Part D reform Definition of Qualified Single Source Drug (QSSD) for purposes of Medicare drug price negotiation Medicare patient access to cancer screening Medicare patient access to rare disease therapies Centers for Medicare and Medicaid Innovation (CMMI) policy issues Value-based payment arrangements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73220,"prefix":null,"prefix_display":null,"first_name":"CAROLINE","nickname":null,"middle_name":null,"last_name":"QUAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147851,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"LANGENDERFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141479,"prefix":"mrs","prefix_display":"MRS.","first_name":"SARAH","nickname":null,"middle_name":"CUDWORTH","last_name":"ARBES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154501,"prefix":null,"prefix_display":null,"first_name":"TALEEN","nickname":null,"middle_name":null,"last_name":"MEKHDJAVAKIAN","suffix":null,"suffix_display":null},"covered_position":"Senator Bill Nelson, FL: Staff Assistant: 2010-2012 Scheduler: 2013-2015 Legislative Correspondent: 2015-2016 Legislative Aide: 2016-2018","new":true},{"lobbyist":{"id":154701,"prefix":"ms","prefix_display":"MS.","first_name":"BAILEY","nickname":null,"middle_name":"LAUREN","last_name":"MCCUE","suffix":null,"suffix_display":null},"covered_position":"Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021 Senator John Cornyn - Legislative Aide April 2022-December 2022 Senator John Boozman - Legislative Assistant, December 2022-February 2025","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmaceutical pricing negotiations Implementation of One Big Beautiful Bill Act law (corporate minimum tax, R&D expensing) Pharmaceutical manufacturing (general education)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73220,"prefix":null,"prefix_display":null,"first_name":"CAROLINE","nickname":null,"middle_name":null,"last_name":"QUAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to patents and intellectual property Patent/IP protections needed for medicines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73220,"prefix":null,"prefix_display":null,"first_name":"CAROLINE","nickname":null,"middle_name":null,"last_name":"QUAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154701,"prefix":"ms","prefix_display":"MS.","first_name":"BAILEY","nickname":null,"middle_name":"LAUREN","last_name":"MCCUE","suffix":null,"suffix_display":null},"covered_position":"Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021 Senator John Cornyn - Legislative Aide April 2022-December 2022 Senator John Boozman - Legislative Assistant, December 2022-February 2025","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax) HR 591 - Defending American Jobs and Investment Act HR 1414 - Camerons Law, to restore orphan drug research tax credit HR 1911 - To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subject to sufficient foreign tax are not treated as base erosion payments HR 1990 - American Innovation and R&D Competitiveness Act of 2025 S.1605 - International Competition for American Jobs Act S.1639 - American Innovation and Jobs Act S.3841 - Last Sale Valuation Act of 2026 Issues related to a Most Favored Nations policy in Medicare and Medicaid Issues related to the renewable energy tax credits and other energy credits included in the Inflation Reduction Act Most Favored Nations and pharmaceutical R&D innovation Most Favored Nation drug pricing proposals Pharmaceutical investment and pricing issues in ex-US countries US trade tools (investigations, tariffs, trade agreements, congressional oversight, rules of origin, CBP enforcement, investment screening) US-Mexico-Canada trade agreement (USMCA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141479,"prefix":"mrs","prefix_display":"MRS.","first_name":"SARAH","nickname":null,"middle_name":"CUDWORTH","last_name":"ARBES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154701,"prefix":"ms","prefix_display":"MS.","first_name":"BAILEY","nickname":null,"middle_name":"LAUREN","last_name":"MCCUE","suffix":null,"suffix_display":null},"covered_position":"Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021 Senator John Cornyn - Legislative Aide April 2022-December 2022 Senator John Boozman - Legislative Assistant, December 2022-February 2025","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax) Most Favored Nations and pharmaceutical R&D innovation Most Favored Nation drug pricing proposals US trade tools (investigations, tariffs, trade agreements, congressional oversight, rules of origin, CBP enforcement, investment screening) US-Mexico-Canada trade agreement (USMCA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Work Opportunity Tax Credit renewal Support for federal and state workforce programs (grants, technical assistance, partnership with federal and state agencies) Support for federally registered apprenticeship programs Support for manufacturing workforce development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax) Tariffs/trade policies related to tariffs on pharmaceuticals Issues related to the renewable energy tax credits and other energy credits included in the Inflation Reduction Act HR 591 - Defending American Jobs and Investment Act HR 1414 - Camerons Law, to restore orphan drug research tax credit HR 1990 - American Innovation and R&D Competitiveness Act of 2025 HR 1911 - To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subject to sufficient foreign tax are not treated as base erosion payments S 1605 - International Competition for American Jobs Act S 1639 - American Innovation and Jobs Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147851,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"LANGENDERFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112411,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7283a169-a2bb-4340-acbc-dcf272a16fc0/","filing_uuid":"7283a169-a2bb-4340-acbc-dcf272a16fc0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7283a169-a2bb-4340-acbc-dcf272a16fc0/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig Monson","dt_posted":"2026-07-20T14:59:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":175642,"url":"https://lda.gov/api/v1/clients/175642/","client_id":1006245,"name":"THE CAMPAIGN FOR SUSTAINABLE RX PRICING","general_description":"A coalition of organizations working on market-based solutions to drug pricing.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-07-12"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/S. 1533 - The Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}